New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification - Takeaways - MDSpire

New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification

  • By

  • Encheng Li

  • Manying Shi

  • Shixiang Huang

  • June 19, 2026

  • 0 min

Share

  • 1

    SARS-CoV-2 infection is associated with increased incidence of allergic diseases, with hazard ratios of 2.25 for asthma and 1.23 for allergic rhinitis.

  • 2

    The mechanisms linking COVID-19 to allergic conditions involve epithelial injury, immune cell reprogramming, and mast cell activation.

  • 3

    Regulatory T cell depletion and altered inflammatory responsiveness may contribute to heightened allergic susceptibility post-infection.

  • 4

    Risk stratification based on disease severity and biomarkers may help identify individuals at risk for allergic diseases after COVID-19.

  • 5

    Proposed interventions such as low-dose interleukin-2 and mast cell stabilizers require further evaluation in convalescent cohorts.

Original Source(s)

New-onset allergic diseases after SARS-CoV-2 infection: mechanistic hypotheses and emerging strategies for risk stratification

  • by Encheng Li, Manying Shi, Shixiang Huang

  • June 19, 2026

Related Content

Utilizing CT chest imaging for the diagnosis and monitoring of COVID infections and emergency intensive care unit strategic treatment

From anaphylaxis to eosinophilic esophagitis during omalizumab treatment in a boy with severe asthma and food allergy: a case report

From immunological mechanisms to targeted therapies: a bibliometric analysis in the domain of research concerning neutrophil extracellular traps and pulmonary diseases (2006–2025)